Skip to content
‹ Back to IndustriesSciences

Demands of Smartphone Camera Quality Drive Manufacturing Process Improvements

The article discusses the improvements in smartphone camera quality and how these demands are driving advancements in manufacturing processes. ZYGO, an optical technology company, is using its Compass microlens process metrology system to ensure that these manufacturing processes meet industry standards. This system helps in controlling the production of high-performance imaging camera modules in smartphones.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

Promoted content from SMART Technologies on MarketScale.

By Sciences · Promoted Content
Share
Demands of Smartphone Camera Quality Drive Manufacturing Process Improvements

Key takeaways

01

One billion smartphones are shipped each year, resulting in countless pictures taken.

02

Cell phone image quality has significantly improved in recent years.

03

ZYGO uses its Compass microlens process to maintain precision in smartphone camera manufacturing.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI in a free MarketScale workspace. Qualifying companies also get one professional video edit a month. No credit card.

Try it Free

With one billion smartphones shipped every year, there are an infinite number of pictures taken by these handheld devices as well. And in the past few years, cell phone image quality has undergone vast improvements. While the average consumer may not have noticed these enhancements, ZYGO has.

Not just because we’re an optical technology company who happen to make clever, innovative products. Rather, it’s because we get to see how our efforts impact the daily lives of millions of people as they capture life’s moments via their smart, but seemingly simple, phones.

Amazingly, these seemingly simple devices are packed with exceedingly smart technologies – one of which is the versatile camera lens module. Each smartphone’s camera lens module consists of multiple discrete lens elements that work in unison to provide high-performance imaging.

We are introducing our solution to the industry, and ultimately consumers – the Compass™ microlens process metrology system. The Compass system in an on-line production control tool that enables the rapid measurement and control of critical micro lenses and lens molds, ensuring that design parameters are being met while keeping the manufacturing process in control.

The Compass system employs proprietary and innovative ZYGO optical technology to uphold the precision, automation, and production throughput standards that can meet both current and future industry needs.

To ensure superior selfies, both now and beyond, check out the revolutionary ZYGO Compass™ micro lens process metrology system.

Read more at zygo.com

SMART Technologies

Part of this channel

SMART Technologies

Interactive learning technology trusted by educators worldwide

Visit the channel

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0. No credit card. Company confirmation required.

More Sciences Insights

CDMOs’ new capacity skews stainless by liters, but single-use leads by system count

CDMOs’ new capacity skews stainless by liters, but single-use leads by system count

Contract Pharma reports bioTRAK data projecting CDMOs will install roughly 120 bioreactors by 2030. It says 71% of added volume is large-scale stainless steel, while 61% of systems are single-use.

  • 01Utilization discipline is still driving builds: BioTRAK’s Dawn Ecker told Contract Pharma expansion conversations typically start after a site is booked above ~80% for several years.

Sep 22, 2026

Pharma supplier diversification means little if every supplier uses the same airport

Pharma supplier diversification means little if every supplier uses the same airport

Biocair's Patrick Wohl argues in Pharmaceutical Commerce that life sciences firms must map airports, sea lanes, customs gateways and carriers alongside suppliers. Suppliers spread across countries can still share one air hub. The fix he describes is pre-qualified alternate routes and continuous review, with clinical trial shipments and cold-chain medicines the first cargo exposed when a corridor closes.

  • 01A supplier base spread across several countries can still be a single point of failure if every shipment routes through one airport hub or corridor; the sharper question for a logistics provider is which hubs each qualified lane actually depends on.
  • 02Gartner data cited by MD+DI gives a benchmark: 42% of procurement leaders rank supply disruption as their organization's top risk, with geopolitical issues including tariffs and regulatory changes ranking third.
  • 03A route map ages fast. Pharmaceutical Commerce published the mapping argument on July 24 and was reporting fresh Red Sea and Iran-related freight risk for pharma lanes by Aug. 10, which is the case for treating mapping as a recurring review rather than a project.

Sep 17, 2026

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Eli Lilly are investing $750 million to expand KwikPen injectable device production at Resilience's Cincinnati-region manufacturing facility, expected to create 400 high-skilled jobs and reach full operations by early 2027. The partnership builds on their collaboration since 2023, which has already produced over 150 million doses of Lilly medications for the U.S. market.

  • 01$750 million investment to expand Resilience's Ohio manufacturing capacity for Eli Lilly's KwikPen injectable device production
  • 02400 new high-skilled jobs expected in Cincinnati region, with full operations by early 2027
  • 03Partnership has already produced over 150 million doses of Lilly medications for the U.S. market since 2023

Sep 14, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512